Trulieve Cannabis Corp (TCNNF)

Cannabis news this week: Gaetz sparks cannabis stock rally, Homeland Security reaffirms seizures, key policy moves and major earnings shake the industry.

Cannabis stocks blazed higher on Thursday after Former Rep. Matt Gaetz (R-Fla.) reportedly said cannabis reform is "on the horizon."

This week's cannabis news: Snoop Dogg expands his cannabis empire, Planet 13 recovers millions, Glass House locks in $50M & top earnings drop.

This week in cannabis news: major acquisitions, regulatory battles, earnings rallies and Ice Cube's new brand launch.

Why cannabis stocks Cronos, Verano, Trulieve and Green Thumb stocks gained on Thursday. A look at their Q4 earnings, market drivers and future outlook.

Trulieve reported fourth-quarter revenue of $301 million, beating analyst estimates of $292.64 million, according to Benzinga Pro. The cannabis company reported fourth-quarter adjusted earnings of 2 cents per share, beating estimates for a loss of 26 cents per share.

Viridian Capital's latest report shows cannabis stocks pricing in no rescheduling or 280E relief, leaving MSOs stuck in valuation limbo.

"Our new combined organization will best position the industry to help the President get them over the finish line," says Trulieve CEO Kim Rivers.

Group behind failed attempt to legalize recreational cannabis in FL has launched new initiative for 2026 ballot. Allows adult use with limits and restrictions.

DEA judge orders agency to respond to allegations of opposing marijuana rescheduling and improper communication with opponents. Cannabis stocks declined in 2024 due to concerns about DEA review.

Surgeon general warns about alcohol's cancer risk, suggests updates to health labels. Cannabis stocks largely rise while alcohol stocks drop.

Triple-digit returns may be just a click of the buy button away.

New Lake Capital Partners (OTC:NLCP), a real estate company focused on cannabis properties, offers an attractive investment with a 9.1% dividend yield, well above the return on 10-year government bonds.

85% of the companies analyzed by Beacon Securities achieved positive adjusted EBITDA for the quarter, an increase from 81% in Q2.

For investors, MariMed represents a fundamentally strong outlier, but industry-wide challenges remain a drag on stock performance.

As the formal review process for rescheduling cannabis unfolds, industry players are closely watching its potential to transform the sector.